Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvar High Grade Squamous Intraepithelial Lesion”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT05104099
What this trial is testing

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia

Who this might be right for
Vulvar Intraepithelial NeoplasiaVulvar High Grade Squamous Intraepithelial LesionDifferentiated Vulvar Intraepithelial Neoplasia
Institut de Cancérologie de Lorraine 17
Post-approval studies (Phase 4)Not Yet RecruitingNCT06052696
What this trial is testing

Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL

Who this might be right for
Vulvar HSILHPV
Erasmus Medical Center 500
Early research (Phase 1)Not Yet RecruitingNCT06233331
What this trial is testing

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Who this might be right for
Human Papilloma VirusHuman Immunodeficiency VirusAnal Intraepithelial Neoplasia+1 more
Emory University 9
Testing effectiveness (Phase 2)Ended earlyNCT03267680
What this trial is testing

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Who this might be right for
Cervical Squamous Cell Carcinoma In SituVulvar High Grade Squamous Intraepithelial Lesion
University of Southern California 10
Early research (Phase 1)Ended earlyNCT03197025
What this trial is testing

Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Human PapillomavirusHPV-16High Grade Squamous Intraepithelial Lesion
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 219
Testing effectiveness (Phase 2)Ended earlyNCT03334240
What this trial is testing

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

Who this might be right for
HPV-Induced Genital Lesions
Maruho Co., Ltd. 28
Early research (Phase 1)Study completedNCT05717621
What this trial is testing

Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN)

Who this might be right for
Vulvar Intraepithelial Neoplasia Grade 2Vulvar Intraepithelial Neoplasia Grade 3
ViMREX GmbH 29
Not applicableEnded earlyNCT02140021
What this trial is testing

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenocarcinoma In SituCervical Intraepithelial Neoplasia+52 more
M.D. Anderson Cancer Center 409
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT03180684
What this trial is testing

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Who this might be right for
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar DysplasiaVulvar Intraepithelial Neoplasia (VIN)+4 more
Inovio Pharmaceuticals 33
Post-approval studies (Phase 4)Ended earlyNCT03051516
What this trial is testing

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Who this might be right for
High Grade Anal Canal Intraepithelial NeoplasiaHigh Grade Vulvar Squamous Intraepithelial Lesion
Fred Hutchinson Cancer Center 188
Testing effectiveness (Phase 2)Ended earlyNCT03937791
What this trial is testing

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Squamous Lntraepithelial Lesions of VulvaNeoplasms, Squamous CellVulvar HSIL
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT06075264
What this trial is testing

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Who this might be right for
Vulvar DiseasesHPV InfectionVulvar HSIL+10 more
Frantz Viral Therapeutics, LLC 27